Polycystic Ovary Syndrome Officially Renamed After 14-Year Study
The new name reflects hormonal and metabolic features, and experts say 70% of people with the condition remain undiagnosed.
- On Tuesday, medical experts announced Polycystic Ovary Syndrome is officially renamed Polyendocrine Metabolic Ovarian Syndrome , concluding a 14-year global consensus process involving thousands of stakeholders worldwide.
- The previous name misleadingly focused on 'cysts' when patients actually have 'arrested follicles,' contributing to missed diagnoses because PMOS impacts metabolic and hormonal systems beyond the ovaries.
- Professor Helena Teede at Monash University led the effort involving 56 organizations and about 22,000 global participants, aiming to improve scientific accuracy and reduce stigma linked to fertility.
- Lorna Berry, an Australian woman with PMOS who helped lead the renaming, called the shift "accountability and progress," saying it will improve care for future generations of women.
- Affecting 1 in 8 women, the condition remains largely undiagnosed; the team plans to integrate the new name into clinical practice over the next three years to ensure equitable healthcare.
171 Articles
171 Articles
A condition that can affect women's fertility and the risk of diabetes is not diagnosed in many cases, but experts hope that giving it a new name will help more patients receive care.
PCOS renamed Polycystic Metabolic Ovarian Syndrome in hopes of improving diagnoses
Polycystic Ovary Syndrome (PCOS) has officially been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), following a landmark 14-year collaboration between Monash University, medical experts, researchers, and patients worldwide. The announcement was made by The Lancet on Tuesday, marking a significant shift in how the condition is understood and discussed globally. The condition affects around one in eight women, impacting more than 170 mil…
The European Congress of Endocrinology decided to identify this disorder that affects many women as a "polyendocrine ovarian metabolic syndrome".
PCOS Got A New Name, One Experts Hope Will Change How Women Receive Care
Javier Zayas Photography/Moment/Getty ImagesChances are you know someone with polycysitc ovary syndrome, or PCOS — it affects roughly 10% to 13% of women of reproductive age (or anyone with ovaries), according to the World Health Organization, though many who suffer with it go undiagnosed. But a change to the condition’s name, published yesterday in The Lancet, aims to change that. Thanks to the work of numerous international women’s health orga…
Polycystic ovary syndrome, also known as PCOS, has a new name
Polycystic ovary syndrome, also known as PCOS, has been renamed polyendocrine metabolic ovarian syndrome, or PMOS. PMOS impacts an estimated 170 million people worldwide and is one of the most common hormonal disorders experienced by women, trans men and nonbinary people assigned female at birth. Black people are more likely to have PMOS and are more likely to have severe forms. Endocrinologist Helena Teede spearheaded the effort. “It was very…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
